	Efficacy and safety of eribulin mesylate vs. docetaxel or paclitaxel, combined with trastuzumab and pertuzumab, as first-line treatment for HER2-positive locally advanced or metastatic breast cancer: updated subgroup analyses of JBCRG-M06/EMERALD. Breast Cancer Res Treat Masuda N, Saji S, Kojima Y, Kitada M, Tada H, Iwasa T, Koizumi K, Iwatani T, Sagara Y, Kuwayama T, Shimoda M, Sasada T, Tsugawa K, Kawaguchi Y, Shimomura A, Yamaguchi T, Hasegawa H, Osaka S, Morita S, Yamashita T. PMID: 42420599 [PubMed - indexed for MEDLINE]
	Current overview of breast cancer risk assessment models - practical application in outpatient gynecological practice. Ceska Gynekol Buryanek A. PMID: 42419955 [PubMed - indexed for MEDLINE]
	Impact of depression on treatment response and survival among patients with breast cancer: A multi-institutional retrospective cohort study. Breast Kong W, He Z, Li D, Li J. PMID: 42419252 [PubMed - as supplied by publisher]
	Ten-year temporal distribution of brain metastases after breast cancer: a global cohort study. J Clin Neurosci de Almeida CC, Santos DH, Machado Magalhães PL, Amaral DC, de Bastos Maximiano ML, Garcia MT, Louzada RN. PMID: 42419089 [PubMed - as supplied by publisher]
	Cell-Assisted Lipotransfer (CAL) and Stromal Vascular Fraction (SVF) in Combination with Autologous Breast Reconstruction: A Preliminary Feasibility Case Series. Aesthetic Plast Surg Nguyen TD, Tran HK, Van Truong P, Tran TPN, Tran HQ, Vo BCD, Dinh NNQ, Nguyen NDA, Pham A. PMID: 42420658 [PubMed - as supplied by publisher]
	Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial. Br J Cancer Sjoquist KM, Dobrovic A, Robledo KP, Nesic K, Baron-Hay S, Ananda S, McCarthy N, Goh J, Steer C, Murray N, Yip S, Mileshkin LR, Fink JL, Chang G, Bailey L, Lee Y, Zebic DS, Kariyawasam UGIU, Shield-Artin K, Jarratt A, Bed, Papenfuss AT, Kondrashova O, Wakefield MJ, Vandenberg CJ, Stockler MR, Scott CL, Waring PM. PMID: 42420629 [PubMed - as supplied by publisher]
	Pregnancy after idiopathic granulomatous mastitis does not increase the rate of disease recurrence: a retrospective cohort study on 54 pregnancies. Sci Rep Alipour S, Shahbazi-Mazid A, Pirjani R, Omranipour R, Aghajani R, Saberi A, Farbod M, Eslami B. PMID: 42420485 [PubMed - as supplied by publisher]
	Rebuilding life after breast cancer treatment among Korean breast cancer survivors: an integrative review. Womens Health Nurs Kim R, Choi SY. PMID: 42419903 [PubMed - indexed for MEDLINE]
	Development and acceptability of gist-based decision aids for prostate and breast cancer screening: a two-phase qualitative interview study in an online setting. BMJ Open Nalavenkata S, Bergengren O, Lynch K, Emard N, Austria M, Martin S, Ogbennaya G, Dualeh K, Stevanovic K, Patel MI, Gonsky J, Vickers A, Fagerlin A, Hamilton JG, Hay JL, Carlsson S. PMID: 42419884 [PubMed - indexed for MEDLINE]
	Genetics, Screening, and Risk-reducing Interventions for Breast Cancer. Surg Clin North Am Le J, Madlensky L, Retson TA, Grossi SM. PMID: 42419307 [PubMed - indexed for MEDLINE]
	Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapies. ESMO Open Kim JW, Park YH, Lee S, Ahn HK, Bae J, Park S, Chae H, Kim JH, Lee KH, Kim MH, Lee KE, Kang MJ, Park IH, Chae YS, Lee GW, Park KU, Lee EM, Park JH, Kim JE, Kim HJ, Kim TH, Oh SY, Ko S, Byun JH, Ha JY, Kwon JH, Lee S, Choi JY, Jung JY, Park KH. PMID: 42419085 [PubMed - as supplied by publisher]
	A Cohort Study of the Effectiveness of Trastuzumab Deruxtecan for Treating Metastatic Progressive HER2-Positive Breast Cancer. Clin Breast Cancer Basta A, Lien K, Ni G, Sun W, Whiting J, Armitage M, Soyano AE, Armaghani A, Loftus L, O'Connor T, Dvir K, Han HS, Soliman H, Czerniecki BJ, Costa RLB. PMID: 42418955 [PubMed - as supplied by publisher]
	A clinical pilot study for personalized risk-based breast cancer screening utilizing a polygenic risk score. PLoS One Hovda T, Sober S, Padrik P, Kruuv-Kao K, Grindedal EM, Vamre TBA, Eikeland E, Hofvind S, Sahlberg KK. PMID: 42418475 [PubMed - indexed for MEDLINE]
	Germline Multigene Panel Testing in Women With Invasive Lobular Cancer. JAMA Netw Open Corso G, Marino E, Fava F, Natali F, Peterlongo P, Dal Molin M, Feroce I, Zanzottera C, Massari G, Di Silvestre S, Moscatiello M, Franceschini A, Bagnardi V, Curigliano G, Bonanni B, Veronesi P, Bertolini F. PMID: 42418202 [PubMed - indexed for MEDLINE]
	Lymphovascular Invasion in SOUND-Eligible Breast Cancer: Implications for Occult Axillary Nodal Metastasis. Ann Surg Oncol Amburn T, Sporn M, Arthurs L, Marsh C, Sharma A, Wu J, DiMaggio C, Axelrod D, Schnabel F, Gemignani ML. PMID: 42418085 [PubMed - as supplied by publisher]
	SERENA-6 and the regulatory limits of radiologic progression in modern oncology. Breast Cancer Res Treat Rafii S, Al-Shamsi HO, Brufsky A. PMID: 42418030 [PubMed - indexed for MEDLINE]
	Omission of sentinel lymph node biopsy in breast cancer: a survey of Brazilian breast surgeons. Einstein (Sao Paulo) Cavalcante ECX, Silva MCA, Lustosa AMCH, Costa REARD, Eulálio Filho WMN, Reis CAD, Valença RJV, Nunes ERCG, Vieira SC. PMID: 42417737 [PubMed - indexed for MEDLINE]
	Mechanosensitive TRPV4 immunohistochemistry improves deep learning-based classification of ductal carcinoma in situ beyond H&E morphology. J Pathol Clin Res Yoo J, Karthikeyan R, Kamat K, Chan C, Samankan S, Arbzadeh E, Schwartz A, Latham PS, Chung I. PMID: 42417209 [PubMed - indexed for MEDLINE]
	Invasive Papillary Carcinoma of the Male Breast: A Diagnostic Reminder. Ann Afr Med Dnyanmote A, Prashanth IAM, Alekhya T. PMID: 42417201 [PubMed - as supplied by publisher]
	The impact of maternal breast cancer diagnosis on the mother-child relationship: an updated systematic review. Curr Opin Support Palliat Care Abdalaty S, Chai GW, Sferrazza D, Leigh J, Arora R, Tang L, Lee SF, Chow E, Wong HCY. PMID: 42417076 [PubMed - as supplied by publisher]

Articles 1 - 20 / 219824

Page 1 of 10992



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy